Biotechnology
Inhibrx: Funding & valuation
Inhibrx has $668.6M paid in by investors, lenders and donors.
Financials
Funding rounds, investors and revenue on record.
$668.6MTotal raised
$448kPublic grants2 public grants
Venture - Series UnknownLatest round
7Rounds and grants
Money by yearUSD, rounds and grants
Largest rounds and grants
$410M
$200M
$40M
$15M
$3.6M
Sources: funding announcements, grant and company registers
Money
Inhibrx has $668.6M paid in by investors, lenders and donors.
$668.6MPaid in
StagePaidSignedAnnouncedSourceFiledAnnouncedPress
Money in
$200MPaid
$15MPaid
$40MPaid
4 more records: amounts, dates and sources of every round, loan and commitmentProUnlockor this company alone for 30 days · 50 credits
Fund markswhat funds reporting to the SEC say their stakes are worth
Funds reporting to the SEC (2) valued their Inhibrx stock at $47k as of Jun 2026.
Price a share in fund marks, by quarter
Marks by fund: shares held, the price a share, the change since the last quarterPremiumUnlockor this company alone for 30 days · 50 credits
People cost
Inhibrx filed a median H-1B wage of $129k in 2025.
$74k–$184kH-1B wage range2 positions
Median H-1B wage by role, 2025scale to $184k
Every row links its own source. A flow two sources state counts once; a figure a source does not state reads "not stated".
